0000000000213002
AUTHOR
F. Godin
LIM Kinases: new anticancer therapeutic targets
International audience
Design, synthesis and biological evaluation of LIMK inhibitors
National audience
LIM kinases as new therapeutic targets for the treatment of neurofibromatosis type 1
International audience
Conception, synthèse et évaluation biologique d’inhibiteurs de LIM kinases
National audience